Risk Reduction to Disease Management: Clinical Pharmacists as Cardiovascular Care Providers

被引:4
作者
Di Palo, Katherine E.
Patel, Khusbu
Kish, Troy
机构
关键词
EMERGENCY-MEDICINE PHARMACIST; TO-NEEDLE TIME; HEART-FAILURE; RANDOMIZED-TRIAL; MYOCARDIAL-INFARCTION; PATIENT-OUTCOMES; AMERICAN-COLLEGE; UNITED-STATES; IMPACT; SMOKING;
D O I
10.1016/j.cpcardiol.2018.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most cardiovascular diseases are caused by modifiable risk factors yet prevalence continues to increase and heart disease remains the leading cause of death in the United States. Screening, identifying and appropriately managing high risk patients are strategies to shift the paradigm from treatment to prevention. Pharmacists are an underutilized population health resource despite robust evidence to support their roles as interdisciplinary team members and direct patient care providers in both inpatient and outpatient settings. This article aims to highlight the multifaceted function and impact of clinical pharmacists on cardiovascular risk reduction and disease management.
引用
收藏
页码:276 / 292
页数:17
相关论文
共 79 条
[1]   THE OUTCOMES OF EMERGENCY PHARMACIST PARTICIPATION DURING ACUTE MYOCARDIAL INFARCTION [J].
Acquisto, Nicole M. ;
Hays, Daniel P. ;
Fairbanks, Rollin J. ;
Shah, Manish N. ;
Delehanty, Joseph ;
Nobay, Flavia ;
Guido, Joseph ;
Haas, Curtis E. .
JOURNAL OF EMERGENCY MEDICINE, 2012, 42 (04) :371-378
[2]   Obesity in coronary heart disease: An unaddressed behavioral risk factor [J].
Ades, Philip A. ;
Savage, Patrick D. .
PREVENTIVE MEDICINE, 2017, 104 :117-119
[3]  
American Coll Clinical Pharm, 2008, PHARMACOTHERAPY, V28, P816, DOI 10.1592/phco.28.6.816
[4]  
[Anonymous], AM COLL CARD 67 SCI
[5]  
[Anonymous], CIRCULATION
[6]  
[Anonymous], COST JUSTIFICATION C
[7]  
[Anonymous], PHARMACOTHERAPY
[8]  
[Anonymous], 2017, 288 NCHS
[9]  
[Anonymous], 2017 NAT DIAB STAT R
[10]  
[Anonymous], EP EUROPACE